Nyxoah Receives $15 Million from the European Investment BankNyxoah Receives $15 Million from the European Investment Bank
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical TechnologyNyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch $110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
Nyxoah to Participate in the Bank of America 2026 Healthcare ConferenceNyxoah to Participate in the Bank of America 2026 Healthcare Conference
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services ConferenceNyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle EastNyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide GrowthNyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
